OR10H5

Across TCGA pan-cancer cohorts, OR10H5 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OR10H5 data layer compared with 12 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher OR10H5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR10H5 expression acts as an unfavorable survival marker.

THYM, SKCM, and COAD are the cancer types where OR10H5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
SKCM	OS	Median	III,IV	0.307	0.737	.001	16	view →
COAD	OS	Median	III,IV	0.159	0.692	.021	15	view →
ACC	OS	Median	All	0.188	0.820	<.001	10	view →
PRAD	DFS	Median	All	0.096	0.935	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR10H5–THYM (OS)

Open the THYM breakdown →